Cumberland Pharmaceuticals Inc (CPIX)

Mar 12, 2025

Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Here’s Why - Defense World

Mar 12, 2025

Mar 10, 2025

Earnings call transcript: Cumberland Q4 2024 results show revenue rise By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 08, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World

Mar 08, 2025

Mar 07, 2025

Cumberland Pharmaceuticals Inc. (CPIX) reports earnings - Quartz

Mar 07, 2025

Mar 07, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call Transcript - MSN

Mar 07, 2025

Mar 07, 2025

Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 05, 2025

Cumberland Pharma stock soars to 52-week high of $7.25 By Investing.com - Investing.com Canada

Mar 05, 2025

Mar 05, 2025

Cumberland Pharmaceuticals: Key Insights from Earnings Call - TipRanks

Mar 05, 2025

Mar 05, 2025

Cumberland Pharma stock soars to 52-week high of $7.25 - Investing.com India

Mar 05, 2025

Mar 05, 2025

Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada

Mar 05, 2025

Mar 05, 2025

Cumberland: Q4 Earnings Snapshot - Midland Daily News

Mar 05, 2025

Mar 04, 2025

Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances - TipRanks

Mar 04, 2025

Mar 04, 2025

Earnings call transcript: Cumberland Q4 2024 results show revenue rise - Investing.com

Mar 04, 2025

Mar 04, 2025

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth - TradingView

Mar 04, 2025

Mar 04, 2025

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth -March 04, 2025 at 04:52 pm EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Cumberland: Q4 Earnings Snapshot -March 04, 2025 at 04:51 pm EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - BioSpace

Mar 04, 2025

Mar 03, 2025

Glenmark Pharmaceuticals Acquires & Launches Acetylcysteine Injection In The U.S. - BW Healthcare World

Mar 03, 2025

Mar 02, 2025

Glenmark acquires Acetylcysteine injection, launches in US market - BusinessLine

Mar 02, 2025

Mar 01, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 117% - Simply Wall St

Mar 01, 2025

Feb 27, 2025

Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Cumberland Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 25, 2025

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS - Quantisnow

Feb 25, 2025

Feb 25, 2025

When Will Cumberland Pharmaceuticals Reveal Its 2024 Performance? Key Date for Specialty Pharma Investors - StockTitan

Feb 25, 2025

Feb 24, 2025

(CPIX) Trading Report - Stock Traders Daily

Feb 24, 2025

Feb 21, 2025

Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet? - Simply Wall St

Feb 21, 2025

Feb 19, 2025

Cumberland Pharma stock soars to 52-week high of $6.43 By Investing.com - Investing.com South Africa

Feb 19, 2025

Feb 19, 2025

Cumberland Pharma stock soars to 52-week high of $6.43 - Investing.com

Feb 19, 2025

Feb 18, 2025

Cumberland Pharmaceuticals' Pneumonia Injection Receives Approval in China -February 18, 2025 at 08:19 am EST - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - Finansavisen

Feb 18, 2025

Feb 18, 2025

Corneal Ulcer Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, NDA Approval, Prevalence, Incidence, Therapies, and Companies by DelveInsight - The Globe and Mail

Feb 18, 2025

Feb 17, 2025

Short Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Decreases By 56.3% - MarketBeat

Feb 17, 2025

Feb 17, 2025

Cumberland Pharmaceuticals Inc. Receives Notification from the U.S. Food and Drug Administration - Marketscreener.com

Feb 17, 2025

Feb 16, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com - MarketBeat

Feb 16, 2025

Feb 15, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Feb 15, 2025

Feb 15, 2025

Cumberland Pharmaceuticals ups common stock offering - MSN

Feb 15, 2025

Feb 14, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.com - Defense World

Feb 14, 2025

Feb 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World

Feb 12, 2025

Feb 10, 2025

An Analysis of Cumberland Pharmaceuticals Inc (CPIX)’s Potential Price Growth - Knox Daily

Feb 10, 2025

Feb 10, 2025

Future Outlook And Stock Price Performance For Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) - Marketing Sentinel

Feb 10, 2025

Feb 10, 2025

Cumberland Pharmaceuticals Inc (CPIX) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Feb 10, 2025

Feb 10, 2025

Cumberland Pharmaceuticals Inc (CPIX) Shares Down Despite Recent Market Volatility - The News Heater

Feb 10, 2025